Advertisement

More articles from Erratum

You have access
Correction to “Commentary on: Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
Molecular Pharmacology November 2020, 98 (5) 598; DOI: https://doi.org/10.1124/molpharm.120.000049err
You have access
Correction to “Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer”
Molecular Pharmacology October 2020, 98 (4) 528; DOI: https://doi.org/10.1124/molpharm.120.000054err
You have access
Correction to “Long-Acting β2-Adrenoceptor Agonists Enhance Glucocorticoid Receptor (GR)–Mediated Transcription by Gene-Specific Mechanisms Rather Than Generic Effects via GR”
Molecular Pharmacology September 2020, 98 (3) 183; DOI: https://doi.org/10.1124/mol.118.112755err
You have access
Correction to “Functional RNAi Screens Define Distinct Protein Kinase Vulnerabilities in EGFR-Dependent HNSCC Cell Lines”
Molecular Pharmacology September 2020, 98 (3) 184; DOI: https://doi.org/10.1124/mol.119.117804err
You have access
Correction to “CXL146, a Novel 4H-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells”
Molecular Pharmacology August 2020, 98 (2) 182; DOI: https://doi.org/10.1124/molpharm.119.000110
You have access
Correction to “MicroRNA hsa-miR-1301-3p Regulates Human ADH6, ALDH5A1 and ALDH8A1 in the Ethanol-Acetaldehyde-Acetate Metabolic Pathway”
Molecular Pharmacology August 2020, 98 (2) 181; DOI: https://doi.org/10.1124/molpharm.120.000109
You have access
Correction to “Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer”
Molecular Pharmacology July 2020, 98 (1) 23; DOI: https://doi.org/10.1124/mol.119.115808err
You have access
Correction to “Pathogen-Associated Molecular Pattern-Induced TLR2 and TLR4 Activation Increases Keratinocyte Production of Inflammatory Mediators and Is Inhibited by Phosphatidylglycerol”
Molecular Pharmacology May 2020, 97 (5) 354; DOI: https://doi.org/10.1124/mol.119.118166err
You have access
Correction to “Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple orthosteric Binding Sites”
Molecular Pharmacology January 2020, 97 (1) 48; DOI: https://doi.org/10.1124/mol.118.118091err
You have access
Correction to “Induction of CYP26A1 by Metabolites of Retinoic Acid: Evidence That CYP26A1 Is an Important Enzyme in the Elimination of Active Retinoids”
Molecular Pharmacology January 2020, 97 (1) 1; DOI: https://doi.org/10.1124/mol.114.096784err

Pages